ADVERSE DRUG REACTIONS TO CHEMOTHERAPY


Publications

  1. Drögemöller BI*, Monzon JG*, Bhavsar AP, Borrie AE, Brooks B, Wright GEB, Liu G, Renouf DJ, Kollmannsberger CK, Bedard PL, Aminkeng F, Amstutz U, Hildebrand CA, Gunaretnam EP, Critchley C, Chen Z, Brunham LR, Hayden MR, Ross CJD, Gelmon KA, Carleton BC. SLC16A5 genetic variation confers protection from cisplatin-induced ototoxicity in adult testicular cancer patientsJAMA Oncol. 2017 Apr 27. doi: 10.1001/jamaoncol.2017.0502. [Epub ahead of print]. *These authors contributed equally to this publication.

Awards

  1. Co-investigator for BC Children’s Research Institute Evidence to Innovation Seed Grant entitled Genome-wide association study of L-asparaginase-induced pancreatitis in pediatric cancer (2017)

  2. Co-investigator for CIHR Project Scheme Grant entitled Discovery, validation, and pre-clinical development of novel strategies to prevent anthracycline-induced cardiotoxicity(2017-2022)

  3. BC Children’s Hospital Research Outstanding Achievement by a Postdoctoral Fellow (2017)

  4. CIHR Postdoctoral Fellowship for project entitled Identification of the genetic variants involved in the development of severe adverse drug reactions in cancer patients treated with cisplatin (2017-2019)

  5. MSFHR Postdoctoral Fellowship for project entitled Unraveling the genetics of severe reactions to chemotherapy: Moving towards maximum benefit with minimal harm (2017-2018)
     
  6. CIHR Drug Safety and Effectiveness Cross‐Disciplinary Training (DSECT) Program for project entitled Genome-wide association study of L-asparaginase-induced pancreatitis in pediatric cancer patients (2017-2018)

  7. Child and Family Research Institute Hoffmeister fellowship for project entitled A comprehensive analysis of the genomic and clinical factors contributing to the occurrence of cisplatin-induced ototoxicity (2015-2016)

  8. Best Basic Science and Overall Poster Presentation at BC Children’s Hospital Research Evidence to Innovation Research Day for poster entitled Genetic variation in SLC16A5 confers protection from cisplatin-induced ototoxicity in adult testicular cancer patients (2016)

  9. Best Poster Presentation at the BC Children’s Hospital Research Trainee Forum for poster entitled Genome-wide association study of L-asparaginase-induced pancreatitis in children (2015)